{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:03Z","timestamp":1786120263253,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/adm.0b013e31821eecfb","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T15:42:23Z","timestamp":1317742943000},"page":"229-231","source":"Crossref","is-referenced-by-count":1,"title":["Is it Time to Reformulate Racemic Methadone?"],"prefix":"10.1097","volume":"5","author":[{"given":"Steven B.","family":"Karch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"R1-11-20210126","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1369-1600.2010.00274.x","article-title":"CYP2B6 and OPRM1 gene variations predict methadone-related deaths.","volume":"16","author":"Bunten","year":"2011","journal-title":"Addict Biol"},{"issue":"1-4","key":"R2-11-20210126","first-page":"705","article-title":"Emergency Department Visits Involving Nonmedical Use of Selected Prescription DrugsUnited States, 2004-2008.","volume":"59","author":"Center","year":"2010","journal-title":"MMWR: Morb Mortal Wkly Rep"},{"issue":"1","key":"R3-11-20210126","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2007.10.009","article-title":"A community-based evaluation of sudden death associated with therapeutic levels of methadone.","volume":"121","author":"Chugh","year":"2008","journal-title":"Am J Med"},{"key":"R4-11-20210126","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (Heroin) addiction. a clinical trial with methadone hydrochloride.","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"issue":"5","key":"R5-11-20210126","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","article-title":"Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.","volume":"81","author":"Eap","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"R6-11-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0376-8716(00)00121-6","article-title":"Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment.","volume":"61","author":"Eap","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"14","key":"R7-11-20210126","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.109.894725","article-title":"Drug-induced arrhythmia.","volume":"122","author":"Heist","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"R8-11-20210126","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/jm00233a011","article-title":"Stereochemical studies on medicinal agents. 21. Investigation of the role of conformational factors in the action of diphenylpropylamines. Synthesis and analgetic potency of 5-methylmethadone diastereomers.","volume":"19","author":"Henkel","year":"1976","journal-title":"J Med Chem"},{"issue":"1","key":"R9-11-20210126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/ewjm.172.1.11","article-title":"Toxicology and pathology of deaths related to methadone: retrospective review.","volume":"172","author":"Karch","year":"2000","journal-title":"West J Med"},{"issue":"4","key":"R10-11-20210126","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.tpj.6500406","article-title":"Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.","volume":"7","author":"Kirchheiner","year":"2007","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"R11-11-20210126","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","article-title":"QTc interval prolongation associated with intravenous methadone.","volume":"105","author":"Kornick","year":"2003","journal-title":"Pain"},{"issue":"6","key":"R12-11-20210126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very-high-dose methadone.","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann Intern Med"},{"key":"R13-11-20210126","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.1976.tb27945.x","article-title":"Drug interactions with methadone.","volume":"281","author":"Kreek","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"R14-11-20210126","first-page":"193","article-title":"Drug interactions with methadone in humans.","volume":"68","author":"Kreek","year":"1986","journal-title":"NIDA Res Monogr"},{"issue":"2","key":"R15-11-20210126","doi-asserted-by":"crossref","first-page":"L45","DOI":"10.1016\/0024-3205(94)00937-6","article-title":"The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine.","volume":"56","author":"Kristensen","year":"1995","journal-title":"Life Sci"},{"issue":"12","key":"R16-11-20210126","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/ja01192a065","article-title":"The resolution of methadone and related compounds.","volume":"70","author":"Larssen","year":"1948","journal-title":"J Am Chem Soc"},{"issue":"4","key":"R17-11-20210126","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1472-8206.2010.00871.x","article-title":"QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.","volume":"25","author":"Perrin-Terrin","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"R18-11-20210126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMcp0706513","article-title":"Clinical practice. Long-QT syndrome.","volume":"358","author":"Roden","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"R19-11-20210126","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00228-008-0504-8","article-title":"Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate.","volume":"64","author":"Seeringer","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"R20-11-20210126","first-page":"706","article-title":"Electrocardiographic changes in heroins, methadone and multiple drug abuse: a postulated mechanism of sudden death in narcotic addicts.","volume":"1","author":"Stimmel","year":"1973","journal-title":"Proc Natl Conf Methadone Treat"},{"issue":"19-20","key":"R21-11-20210126","first-page":"282","article-title":"Methadone-induced Torsade de pointes tachycardias.","volume":"135","author":"Sticherling","year":"2005","journal-title":"Swiss Med Wkly"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01271255-201109000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:21:56Z","timestamp":1786047716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01271255-201109000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e31821eecfb","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}